The 2021 and 2023 approvals of Novo Nordisks Wegovy and Eli Lillys Zepbound, respectively, ignited a GLP-1 market that is expected to exceed $100 billion in the next decade
But here is the critical distinction
Medical summaries indicate that enhanced blood supply due to angiogenesis may support tumor growth
Seven drugs have currently been approved for the treatment of Type 2 diabetes mellitus, including short-acting agents like exenatide and lixisenatide, as well as long-acting injectable agents such as albiglutide, dulaglutide, liraglutide, and semaglutide. GLP-1s regulate lipid metabolism, reducing the effects of hyperlipidemia and helping to lower the risk for both chronic kidney disease (CKD) and diabetic kidney disease. They have also been shown to reduce oxidative stress, which includes stimulating glomerular filtration and reducing vasoconstriction, slowing the progression of CKD. Limited data from clinical trials have been published on the effects of GLP-1 receptor agonists in individuals with post-liver transplant diabetes mellitus (PTDM)
The standard recommendation for reconstituted tirzepatide is 28 days when stored refrigerated at 2 to 8 degrees Celsius
